回首頁使用說明回臺大首頁 │ 
 
回上一頁
公告主旨 [演講] 7/14 顧正崙 老師 主講:Return of the Anti-IFN-γ: From Disease Mechanism to Therapeutic Approach
公告單位 醫學院--基因體暨蛋白體醫學研究所
公告時間 2025/6/17 下午 02:56:54
公告內容 臺大基蛋所Medical Genetics & Genomics Monthly Seminar演講邀請

[講題]:Return of the Anti-IFN-γ: From Disease Mechanism to Therapeutic Approach

[講者]:顧正崙 特聘教授(長庚大學 分子免疫中心)

CV:https://www.mc.ntu.edu.tw/medgenpro/News.action?q_type=-1&q_itemCode=10394

[時間]:2025/7/14 (星期一) 上午11:20-12:10

[Hybrid Meeting]:
*地點: 醫學院基醫大樓202講堂
*Webex: https://ntumc.webex.com/ntumc-tc/j.php?MTID=m1580d80b620c776de3eb12b9c165523c

[摘要]
Anti–interferon-γ autoantibodies (AIGAs) are key drivers of adult-onset immunodeficiency in Southeast Asia, predisposing individuals to infections such as Talaromyces marneffei and nontuberculous mycobacteria. Using single-cell capture, we cloned 19 monoclonal AIGAs and identified three distinct epitopes on IFN-γ. While all clones exhibited high-affinity binding (KD < 10⁻⁹ M), only a subset neutralized IFN-γ–STAT1 signaling. Mechanistic studies revealed that epitope group I antibodies block IFN-γ binding to IFN-γR1, whereas group II and III antibodies interfere with IFN-γR1–R2 dimerization even after receptor engagement. Notably, group III antibodies also mediated antibody-dependent cellular cytotoxicity (ADCC), potentially depleting IFN-γ–responsive cells. To therapeutically eliminate these pathogenic antibodies, we developed IFN-γ chimeric autoantibody receptor (CAAR) T cells using an engineered, receptor-nonbinding IFN-γ variant. These CAAR T cells selectively targeted autoreactive B cells from patients, reduced circulating AIGAs in a mouse model, and avoided off-target and Fc-mediated toxicity. This precision approach offers a promising strategy for restoring IFN-γ immunity in affected patients. Meanwhile, due to their potent and specific cytokine-blocking activity, AIGAs are also being repurposed as therapeutic agents for IFN-γ–driven autoimmune diseases such as vitiligo, where IFN-γ contributes to melanocyte destruction. Our work highlights both the pathogenic mechanisms of AIGAs and innovative therapeutic strategies that transform disease insights into clinical applications.

歡迎踴躍參加!

◎每月精彩演講已放到網路上囉,歡迎大家一起來重溫精彩內容!http://speech.ntu.edu.tw/ntuspeech/Cate/index/id-3

◎歡迎加入演講FB社團,掌握最新演講消息:Medical Genetics & Genomics Monthly Seminar https://www.facebook.com/groups/1109733759041652/

臺大基蛋所 與 臺大醫院基因醫學部 敬邀
相關聯合國永續
發展目標(SDGs)
SDG03 健康與福祉
活動費用 免費
活動時間 2025/7/14 到 2025/7/14
活動地點 臺大醫學院基醫大樓202講堂
公告對象 教職員、學生、校友、其他
附件名稱  檔案大小 
演講海報  185018 Bytes
回上一頁
版權所有 國立台灣大學 計算機及資訊網路中心
10617 臺北市羅斯福路四段一號
TEL:(02)3366-5022或3366-5023
建議最佳螢幕解析度 1024*768